206 related articles for article (PubMed ID: 2752713)
61. Comparison of disc-diffusion and plate-incorporation susceptibility testing of gram-negative bacilli to ticarcillin, piperacillin and ticarcillin/clavulanate.
Elston RA; Swann RA; Fraise A
J Antimicrob Chemother; 1989 Feb; 23(2):285-7. PubMed ID: 2708186
[No Abstract] [Full Text] [Related]
62. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. I. The combined effect of arbekacin with fosfomycin or clavulanic acid/ticarcillin].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1992 Aug; 45(8):949-57. PubMed ID: 1433901
[TBL] [Abstract][Full Text] [Related]
63. Potential effects of amoxycillin/clavulanic acid and ticarcillin/clavulanic acid on human granulocyte activity: a comparative study.
Cuffini AM; Tullio V; Paizis G; Carlone NA
J Antimicrob Chemother; 1996 Dec; 38(6):1013-22. PubMed ID: 9023648
[TBL] [Abstract][Full Text] [Related]
64. [Antimicrobial activities of clavulanic acid/ticarcillin against clinical isolates].
Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Deguchi K; Oda S; Nakane Y; Fukumoto T
Jpn J Antibiot; 1995 Dec; 48(12):1899-905. PubMed ID: 8587164
[TBL] [Abstract][Full Text] [Related]
65. Timentin versus piperacillin in the treatment of hospitalized patients with urinary tract infections.
Cox CE
J Antimicrob Chemother; 1986 May; 17 Suppl C():93-6. PubMed ID: 3636340
[TBL] [Abstract][Full Text] [Related]
66. A comparison of agar dilution, identification of beta-lactamases and disc diffusion methods for assessing the sensitivity to ticarcillin-clavulanic acid.
Joly B; Chanal M; Sirot D; Cluzel M; Sirot J; Cluzel R
J Antimicrob Chemother; 1986 May; 17 Suppl C():27-33. PubMed ID: 3522530
[TBL] [Abstract][Full Text] [Related]
67. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate and sulbactam combined with extended-spectrum penicillins against ticarcillin-resistant Enterobacteriaceae and pseudomonads.
Jacobs MR; Aronoff SC; Johenning S; Yamabe S
J Antimicrob Chemother; 1986 Aug; 18(2):177-84. PubMed ID: 3019984
[TBL] [Abstract][Full Text] [Related]
68. Comparative in-vitro activities of azlocillin, ticarcillin and ticarcillin plus clavulanic acid against Staphylococcus aureus, Klebsiella pneumoniae and Pseudomonas aeruginosa.
Lagast H; Husson M; Klastersky J
J Antimicrob Chemother; 1985 May; 15(5):633-6. PubMed ID: 3924883
[TBL] [Abstract][Full Text] [Related]
69. In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis, Mycobacterium avium, Mycobacterium fortuitum, and Mycobacterium chelonae to ticarcillin in combination with clavulanic acid.
Casal MJ; Rodriguez FC; Luna MD; Benavente MC
Antimicrob Agents Chemother; 1987 Jan; 31(1):132-3. PubMed ID: 3105441
[TBL] [Abstract][Full Text] [Related]
70. In vitro activities of antibacterial agents against clinical isolates of Escherichia coli and Klebsiella species from intensive care units.
Gill CJ; Ponticas S; Shungu DL; Guerriero S
Clin Ther; 1991; 13(1):25-37. PubMed ID: 2029725
[TBL] [Abstract][Full Text] [Related]
71. Comparative activities in vitro of timentin (ticarcillin/clavulanic acid) and ureidopenicillins against ampicillin-resistant clinical isolates.
Griffin KE; Slocombe B
J Chemother; 1989 Jul; 1(4 Suppl):267-9. PubMed ID: 16312396
[No Abstract] [Full Text] [Related]
72. Ticarcillin-clavulanic acid therapy in severe infections.
Van der Auwera P; Legrand JC
Drugs Exp Clin Res; 1985; 11(11):805-13. PubMed ID: 3836862
[TBL] [Abstract][Full Text] [Related]
73. In vitro anaerobic data on ticarcillin/clavulanate. A review of an ongoing survey.
Sanders CV; Aldridge KE
J Reprod Med; 1990 Mar; 35(3 Suppl):313-6. PubMed ID: 2319513
[TBL] [Abstract][Full Text] [Related]
74. [Comparative bacteriostatic activity of ticarcillin, alone and combined with clavulanic acid, 5 cephalosporins and metronidazole against 100 strains of Bacteroides fragilis].
de Barbeyrac B; Quentin C; Bebear C
Pathol Biol (Paris); 1984 May; 32(5):433-5. PubMed ID: 6739151
[TBL] [Abstract][Full Text] [Related]
75. [Apalcillin: in vitro activity compared with that of carbenicillin, ticarcillin, mezlocillin, piperacillin against Enterobacteriaceae and Acinetobacter].
Quentin C; Sageaux JC; Bebear C; Latrille J
Pathol Biol (Paris); 1983 Jun; 31(6):463-6. PubMed ID: 6224123
[TBL] [Abstract][Full Text] [Related]
76. Comparative antibacterial activity of the aminothiazolyl cephalosporin RU 29,246.
Qadri SM; Ueno Y; Saldin H; Tullo DD; Lee GC
Chemotherapy; 1993; 39(3):175-81. PubMed ID: 8508687
[TBL] [Abstract][Full Text] [Related]
77. Ex vivo pharmacodynamic study of piperacillin alone and in combination with tazobactam, compared with ticarcillin plus clavulanic acid.
Van der Auwera P; Duchateau V; Lambert C; Husson M; Kinzig M; Sörgel F
Antimicrob Agents Chemother; 1993 Sep; 37(9):1860-8. PubMed ID: 8239597
[TBL] [Abstract][Full Text] [Related]
78. Detection of ticarcillin-clavulonic acid susceptibility with microdilution method in Citrobacter, Hafnia, Proteus and some gram negative bacteria.
Uraz G; Oncül O
Drug Metabol Drug Interact; 2004; 20(3):185-91. PubMed ID: 15508433
[TBL] [Abstract][Full Text] [Related]
79. Timentin and beta-lactamases.
Labia R; Morand A; Péduzzi J
J Antimicrob Chemother; 1986 May; 17 Suppl C():17-26. PubMed ID: 3487538
[TBL] [Abstract][Full Text] [Related]
80. Antibacterial effects of ticarcillin/clavulanic acid in animal models of infection.
Boon RJ; Beale AS; Sutherland R
J Antimicrob Chemother; 1986 May; 17 Suppl C():41-6. PubMed ID: 3087934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]